Published in IEEE Trans Vis Comput Graph on January 05, 2005
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol (2008) 13.96
Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat Methods (2008) 11.61
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Medical sequencing at the extremes of human body mass. Am J Hum Genet (2007) 5.61
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res (2009) 4.11
The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med (2005) 4.07
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med (2011) 3.79
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr (2006) 2.73
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
For the law, neuroscience changes nothing and everything. Philos Trans R Soc Lond B Biol Sci (2004) 2.46
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Sepsis: time to reconsider the concept. Crit Care Med (2008) 2.17
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med (2006) 2.04
The geometric median on Riemannian manifolds with application to robust atlas estimation. Neuroimage (2008) 2.01
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock (2005) 1.97
Training with the compactEASIE biologic endoscopy simulator significantly improves hemostatic technical skill of gastroenterology fellows: a randomized controlled comparison with clinical endoscopy training alone. Gastrointest Endosc (2005) 1.96
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91
A systematic review of population screening for fragile X syndrome. Genet Med (2010) 1.87
Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. Ann Surg (2014) 1.82
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother (2006) 1.70
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet (2002) 1.69
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med (2008) 1.57
Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med (2003) 1.51
Functional architecture and evolution of transcriptional elements that drive gene coexpression. Science (2007) 1.51
A prospective, randomized comparison of long-term outcomes: chronic groin pain and quality of life following totally extraperitoneal (TEP) and transabdominal preperitoneal (TAPP) laparoscopic inguinal hernia repair. Surg Endosc (2013) 1.50
Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr (2006) 1.50
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Addressing the educational void during the antiretroviral therapy rollout. AIDS (2004) 1.45
HIV testing experiences among male and female inmates in Rhode Island. AIDS Read (2007) 1.45
Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med (2015) 1.45
Comparison of metabolic monitors in critically ill, ventilated patients. Nutrition (2006) 1.44
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Gastrointest Endosc (2006) 1.42
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
Sequence features that drive human promoter function and tissue specificity. Genome Res (2010) 1.40
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun (2013) 1.37
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis (2007) 1.36
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol (2005) 1.32
Laparoscopic inguinal hernia repair: transabdominal preperitoneal (TAPP) versus totally extraperitoneal (TEP) approach: a prospective randomized controlled trial. Surg Endosc (2011) 1.30
ERCP core curriculum. Gastrointest Endosc (2006) 1.30
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
"Opt-out" testing for HIV in Africa: a caution. Lancet (2004) 1.30
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care (2013) 1.29
Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides. Ther Clin Risk Manag (2008) 1.27
Antileishmanial activity of nano-amphotericin B deoxycholate. J Antimicrob Chemother (2008) 1.26
The less they know, the better: abstinence-only HIV/AIDS programs in Uganda. Reprod Health Matters (2006) 1.25
Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J Immunol (2002) 1.25
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol (2002) 1.24
Health benefits of legal services for criminalized populations: the case of people who use drugs, sex workers and sexual and gender minorities. J Law Med Ethics (2010) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Excellence in endoscopy: toward practical metrics. Gastrointest Endosc (2006) 1.15
Predictors of stress in mothers and fathers of children with fragile X syndrome. Res Dev Disabil (2005) 1.13
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine (2011) 1.13
Evaluation of antioxidant potential of ethyl acetate extract/fractions of Acacia auriculiformis A. Cunn. Food Chem Toxicol (2007) 1.13
Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr (2010) 1.12
Lives to save: PEPFAR, HIV, and injecting drug use in Africa. Lancet (2009) 1.11
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Readmission to the intensive care unit after "fast-track" cardiac surgery: risk factors and outcomes. Ann Thorac Surg (2003) 1.09
The Neo-Papilla: a new modification of porcine ex vivo simulators for ERCP training (with videos). Gastrointest Endosc (2006) 1.07
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04
Changes in regional distribution of lung sounds as a function of positive end-expiratory pressure. Crit Care (2009) 1.04
Monetary benefits of preventing childhood lead poisoning with lead-safe window replacement. Environ Res (2007) 1.03
Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc (2014) 1.03
Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg (2004) 1.02
Maximum surgical blood ordering schedule in a tertiary trauma center in northern India: A proposal. J Emerg Trauma Shock (2012) 1.02
Comparison of long-term outcome and quality of life after laparoscopic repair of incisional and ventral hernias with suture fixation with and without tacks: a prospective, randomized, controlled study. Surg Endosc (2012) 1.02
A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med (2008) 1.00
Traumatic diaphragmatic injury: a review of CT signs and the difference between blunt and penetrating injury. Diagn Interv Radiol (2014) 1.00
Efficacy and costs of a one-day hands-on EASIE endoscopy simulator train-the-trainer workshop. Gastrointest Endosc (2005) 1.00
The potential of stem cells in the treatment of knee cartilage defects. Knee (2010) 0.99
Duodenal perforation following blunt abdominal trauma. J Emerg Trauma Shock (2011) 0.99
HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol (2004) 0.98
Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int (2005) 0.97
Thoracoscopy: the preferred approach for the resection of selected posterior mediastinal tumors. J Laparoendosc Adv Surg Tech A (2002) 0.97
Testicular functions, chronic groin pain, and quality of life after laparoscopic and open mesh repair of inguinal hernia: a prospective randomized controlled trial. Surg Endosc (2011) 0.97
Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features. Proc Natl Acad Sci U S A (2006) 0.96
A Highly Abbreviated Synthesis of Dibenzo[def,p]chrysene and Its 12-Methoxy Derivative, a Key Precursor for the Synthesis of the Proximate and Ultimate Carcinogens of Dibenzo[def,p]chrysene. J Org Chem (2004) 0.96
Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome. Neurosci Biobehav Rev (2013) 0.95
Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun (2002) 0.95
Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains. Infect Immun (2010) 0.95
The in vitro cytotoxic and apoptotic activity of Triphala--an Indian herbal drug. J Ethnopharmacol (2004) 0.95
Quality indicators for endoscopic ultrasonography. Gastrointest Endosc (2006) 0.94
Quality indicators for endoscopic ultrasonography. Am J Gastroenterol (2006) 0.94